Merck | MRK - Sales Revenues



Merck reported EUR4.43B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Adidas EUR 5.95B 203M Jun/2025
Adyen EUR 1.09B 558.7M Jun/2025
Akzo Nobel EUR 2.63B 20M Jun/2025
Alcon AG USD 2.58B 130M Jun/2025
Amadeus IT EUR 1.63B 2.2M Jun/2025
Amarin USD 72.74M 30.72M Jun/2025
AstraZeneca USD 14.46B 867M Jun/2025
BASF EUR 15.77B 1.63B Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Beiersdorf EUR 2.5B 190M Jun/2025
Covestro EUR 3.38B 90M Jun/2025
Danone EUR 6.91B 6.71B Jun/2025
Fresenius EUR 5.58B 70M Jun/2025
Fresenius Medical Care EUR 4.79B 90M Jun/2025
Galapagos EUR 70.17M 4.81M Jun/2025
Genmab DKK 5.86B 580M Jun/2025
Givaudan CHF 1.87B 1.51B Jun/2024
GlaxoSmithKline GBP 7.99B 470M Jun/2025
GRIFOLS EUR 1.89B 100M Jun/2025
Henkel EUR 5.16B 80M Jun/2025
Hikma Pharmaceutical USD 1.59B 18M Dec/2024
Infineon EUR 3.7B 110M Jun/2025
Linde USD 8.5B 213M Jun/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 4.43B 850M Jun/2025
Novartis USD 14.05B 821M Jun/2025
Philips EUR 4.34B 241M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
Sanofi EUR 9.99B 90M Jun/2025
UCB EUR 3.49B 129M Jun/2025